Skip to main content

Closed

MYGN: Myriad Genetics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Medical - Diagnostics & Research

52W Range

1thpctl

Volume

9.21×avg

Market Cap

270.12MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Myriad Genetics, Inc.

MYGNNASDAQ·USD·Closed

Myriad Genetics, Inc.

MYGNNASDAQ·USD·Closed

$2.86

−46.74%

$2.86

−$2.51 (46.74%)

52W Range

1thpctl

Volume

9.21×avg

Mkt Cap

270.12MUSD

P/E

-2.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings